
Atomwise is an artificial intelligence platform for drug discovery.
Atomwise develop AI to help their partners overcome the challenges of drug discovery. Some of their partners are bridgebio, Hansoh, Tulane University, Lilly, Bayer, abbvie, Stempnix etc. Its AI-powered discovery portfolio includes an internally developed pipeline, JVs, academic and biopharma development partners, and is backed by prominent investors.
Frequently Asked Questions